Written Question·Department of Health and Social Care·UIN 38494

Givinostat

Tabled: 14 March 2025

Answered: 26 March 2025

Question

Dr Neil Shastri-Hurst

Conservative — Solihull West and Shirley

To ask the Secretary of State for Health and Social Care, what discussions his Department has had with (a) NHS England and (b) ITF Pharma UK to ensure that NHS Trusts have the necessary resources and guidance to take part in the Early Access Programme for

Answer

Karin Smyth

The Department understands the impact that Duchenne muscular dystrophy has on those living with it and their families, and the urgent need for new treatment options. The National Institute for Health and Care Excellence (NICE) recently published guidance ...

ⓘ

This is an extract from the Parliament API. Search the full answer on Parliament.uk (UIN 38494) →